Amundi Asset Management US’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$642M Buy
5,927,925
+134,093
+2% +$14.3M 0.49% 42
2020
Q4
$621M Buy
5,793,832
+805,938
+16% +$77.4M 0.53% 38
2020
Q3
$437M Sell
4,987,894
-55,863
-1% -$5.26M 0.46% 45
2020
Q2
$495M Buy
5,043,757
+207,343
+4% +$18.3M 0.59% 28
2020
Q1
$238M Sell
4,836,414
-282,544
-6% -$24.1M 0.42% 55
2019
Q4
$453M Buy
5,118,958
+1,062,262
+26% +$88.2M 0.53% 39
2019
Q3
$307M Buy
4,056,696
+429,761
+12% +$29.5M 0.46% 41
2019
Q2
$1.8B Sell
3,626,935
-271,864
-7% -$21.4M 1.48% 5
2019
Q1
$314M Buy
3,898,799
+585,248
+18% +$47.9M 0.44% 55
2018
Q4
$305K Buy
3,313,551
+587,048
+22% +$51.6M 0.28% 51
2018
Q3
$258M Buy
2,726,503
+1,483,527
+119% +$141M 0.34% 69
2018
Q2
$115M Sell
1,242,976
-103,145
-8% -$10.1M 0.17% 139
2018
Q1
$127M Sell
1,346,121
-50,091
-4% -$5.5M 0.2% 121
2017
Q4
$135M Buy
+1,396,212
New +$132M 0.21% 124
2017
Q1
Sell
-112,829
Closed -$7.07M 523
2016
Q4
$7.07M Sell
112,829
-1,018,165
-90% -$62.1M 0.02% 348
2016
Q3
$71.3M Sell
1,130,994
-150,956
-12% -$9.77M 0.26% 88
2016
Q2
$79.4M Buy
1,281,950
+20,516
+2% +$1.25M 0.29% 89
2016
Q1
$72.1M Buy
1,261,434
+111,360
+10% +$6.21M 0.27% 88
2015
Q4
$68.1M Sell
1,150,074
-1,136,888
-50% -$65.5M 0.25% 102
2015
Q3
$124M Sell
2,286,962
-414,655
-15% -$27M 0.51% 58
2015
Q2
$182M Buy
2,701,617
+333,476
+14% +$21.8M 0.66% 34
2015
Q1
$139M Sell
2,368,141
-734,052
-24% -$44.3M 0.5% 59
2014
Q4
$203M Buy
3,102,193
+500,357
+19% +$31.5M 0.74% 27
2014
Q3
$150M Buy
2,601,836
+587,255
+29% +$32.6M 0.57% 48
2014
Q2
$114M Sell
2,014,581
-31,095
-2% -$1.63M 0.44% 74
2014
Q1
$105M Buy
2,045,676
+8,573
+0.4% +$433K 0.4% 76
2013
Q4
$108M Sell
2,037,103
-2,406
-0.1% -$118K 0.41% 75
2013
Q3
$91.2M Sell
2,039,509
-22,842
-1% -$1.01M 0.37% 81
2013
Q2
$85.3M Buy
+2,062,351
New +$90.2M 0.36% 89

Other funds holding ABBV